Veru (VERU) Change in Acquisitions & Divestments (2011 - 2026)
Veru (VERU) posted quarterly Change in Acquisitions & Divestments of $3.2 million for Q1 2026, up 713.8% quarter-over-quarter from $393217.0 in Q4 2024.
Veru (VERU) Change in Acquisitions & Divestments (2011 - 2026) Analysis & Trends
Veru (VERU) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (up 713.8% YoY), while the FY2025 annual figure was $393217.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments rose to $3.2 million in Q1 2026 per VERU's latest filing, from $393217.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $3.2 million in Q1 2026 and bottomed at $393217.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Jun 30, 2026 | 1.80 Mn |
| Mar 31, 2026 | 3.20 Mn |
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2024 | 393,217.00 |
| Dec 31, 2024 | 393,217.00 |
| Dec 31, 2011 | 64,127.00 |
| Dec 31, 2011 | 64,127.00 |